| __timestamp | Bio-Techne Corporation | Corcept Therapeutics Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 30945000 | 18372000 |
| Thursday, January 1, 2015 | 40853000 | 15419000 |
| Friday, January 1, 2016 | 45187000 | 23844000 |
| Sunday, January 1, 2017 | 53514000 | 40376000 |
| Monday, January 1, 2018 | 55329000 | 75247000 |
| Tuesday, January 1, 2019 | 62413000 | 89017000 |
| Wednesday, January 1, 2020 | 65192000 | 114764000 |
| Friday, January 1, 2021 | 70603000 | 113864000 |
| Saturday, January 1, 2022 | 87140000 | 130991000 |
| Sunday, January 1, 2023 | 92493000 | 184353000 |
| Monday, January 1, 2024 | 96664000 |
Cracking the code
In the competitive world of biotechnology, innovation is the lifeblood of success. Bio-Techne Corporation and Corcept Therapeutics Incorporated have been at the forefront of this race, investing heavily in research and development (R&D) over the past decade. From 2014 to 2023, Bio-Techne consistently increased its R&D spending, peaking at approximately $92 million in 2023, a threefold increase from 2014. Meanwhile, Corcept Therapeutics has shown an even more aggressive growth trajectory, with R&D expenses soaring by over 900% from 2014 to 2023, reaching nearly $184 million.
This data highlights a significant trend: while both companies are committed to innovation, Corcept Therapeutics has been more aggressive in scaling its R&D investments. This strategic focus on innovation could be a key differentiator in the biotech industry, where breakthroughs can lead to substantial market advantages.
Comparing Innovation Spending: Merck & Co., Inc. and Bio-Techne Corporation
Teva Pharmaceutical Industries Limited or Bio-Techne Corporation: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Summit Therapeutics Inc. vs Bio-Techne Corporation
Research and Development Expenses Breakdown: Bio-Techne Corporation vs Opthea Limited
Analyzing R&D Budgets: Bio-Techne Corporation vs MorphoSys AG
Analyzing R&D Budgets: Bio-Techne Corporation vs Arrowhead Pharmaceuticals, Inc.
Comparing Innovation Spending: Bio-Techne Corporation and Amphastar Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Bio-Techne Corporation vs Travere Therapeutics, Inc.
Corcept Therapeutics Incorporated or CymaBay Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Corcept Therapeutics Incorporated and Xenon Pharmaceuticals Inc.
Corcept Therapeutics Incorporated or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Corcept Therapeutics Incorporated vs Evotec SE